UK Earnings, Trading Statements Calendar | |
Wednesday, February 4 | |
GlaxoSmithKline | Full Year Results |
Hargreaves Lansdown | Half Year Results |
International Consolidated Airlines Group | January Traffic Statistics |
Sky | Half Year Results |
Victrex | Interim Management Statement |
Daily Mail and General Trust | Trading Statement |
GW Pharmaceuticals | Q1 Results |
Thursday, February 5 | |
Fusionex International | Full Year Results |
McBride | Interim Results |
Compass Group | Interim Management Statement |
Beazley | Full Year Results |
AstraZeneca | Full Year Results |
EasyJet | January Traffic Statistics |
Dairy Crest Group | Interim Management Statement |
Future | Interim Management Statement |
Enterprise Inns | Interim Management Statement |
Grainger | Interim Management Statement |
Smith & Nephew | Full Year Results |
Vodafone Group | Interim Management Statement |
Avanti Communications Group | Half Year Results |
Friday, February 6 | |
Shaftesbury | AGM Statement |
Monday, February 9 | |
Randgold Resources | Full Year Results |
Tuesday, February 10 | |
Catlin Group | Full Year Results |
Cable & Wireless Communications | Trading Statement |
Vernalis | Half Year Results |
Bellway | Trading Update |
Halma | Trading Update |
ICAP | Q3 Interim Management Statement |
Millennium & Copthorne Hotels | Full Year Results |
Copyright 2015 Alliance News Limited. All Rights Reserved. | |
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.
Read more